Novo Holdings antibiotic fund makes second investment in US-based AMR firm
US antibiotic company Revagenix has completed a Series B funding round that has provided the company with a significant amount of funding from investors including Novo Holdings’ Repair Impact Fund.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.